These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1000515)

  • 1. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
    Eagan RT; Hahn RG; Myers RP
    Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of adriamycin (NSC-123127) and the combination of 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in advanced prostatic cancer: a preliminary report.
    Eagan RT; Utz DC; Myers RP; Furlow WL
    Cancer Chemother Rep; 1975; 59(1):203-7. PubMed ID: 1093666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
    Stephens RL; Hoogstraten B
    Cancer Chemother Rep; 1974; 58(6):943-5. PubMed ID: 4614901
    [No Abstract]   [Full Text] [Related]  

  • 4. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
    Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
    Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
    [No Abstract]   [Full Text] [Related]  

  • 5. [Combination cytostatic chemotherapy of advanced metastatic cancer of the prostate. A preliminary uncontrolled study].
    Ogaard S; Jensen TS
    Ugeskr Laeger; 1977 Feb; 139(9):515-7. PubMed ID: 841743
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
    Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
    Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of advanced carcinoma of the prostate with 5-fluorouracil, cyclophosphamide and adriamycin.
    Merrin C; Etra W; Wajsman Z; Baumgartner G; Murphy G
    J Urol; 1976 Jan; 115(1):86-8. PubMed ID: 1107604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin in the treatment of advanced breast cancer; comparative studies of three combination chemotherapy regimes.
    Brown I; Ward HW
    Clin Oncol; 1976 Jun; 2(2):105-11. PubMed ID: 954258
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma.
    Collier D; Soloway MS
    Urology; 1976 Nov; 8(5):459-64. PubMed ID: 982733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of combination of cyclophosphamide, adriamycin and platinum (CAP) versus cyclophosphamide, adriamycin and 5-fluorouracil (CAF) in metastatic breast cancer.
    Tzekova V; Velikova M; Koynov K; Micheva D; Donchev T
    Neoplasma; 1991; 38(6):603-7. PubMed ID: 1766485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
    Bruckner HW; Deppe G
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of adriamycin and cyclophosphamide in the treatment of metastatic prostatic carcinoma: a phase II study.
    Izbicki RM; Amer MH; Al-Sarraf M
    Cancer Treat Rep; 1979 Jun; 63(6):999-1001. PubMed ID: 380805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muehrcke's lines on nails after cyclophosphamide/adriamycin/fluorouracil.
    Gül U; Kiliç A
    Ann Pharmacother; 2004 Jun; 38(6):1089-90. PubMed ID: 15122002
    [No Abstract]   [Full Text] [Related]  

  • 15. Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
    Pannuti F; Rossi AP; Di Marco AR; Fruet F; Lelli G; Strocchi E; Rocchetta G; Piana E; Martoni A
    Panminerva Med; 1981; 23(1):25-8. PubMed ID: 7290722
    [No Abstract]   [Full Text] [Related]  

  • 16. [Estrogen-resistant prostatic cancer with bone metastases: palliative chemotherapy with 5-fluorouracil and cyclophosphamide].
    Küss R; Khoury S; Richard F; Fourcade R; Frantz P; Capelle JP
    Nouv Presse Med; 1978 Aug 26-Sep 2; 7(28):2478-9. PubMed ID: 80785
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
    Lloyd RE; Jones SE; Salmon SE; Durie BG; McMahon LJ
    Cancer Treat Rep; 1976 Jan; 60(1):77-83. PubMed ID: 1000520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy of advanced prostatic cancer today.
    Murphy GP; Merrin CE
    Prog Clin Biol Res; 1976; 6():285-99. PubMed ID: 139614
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the therapeutic effects of adriamycin alone versus adriamycin plus vincristine versus adriamycin plus cyclophosphamide in the treatment of advanced carcinoma of the cervix.
    Wallace HJ; Hreshchyshyn MM; Wilbanks GD; Boronow RC; Fowler WC; Blessing JA
    Cancer Treat Rep; 1978 Oct; 62(10):1435-41. PubMed ID: 709549
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy for metastatic breast cancer: comparison of multiple drug therapy with 5-fluorouracil, cytoxan and prednisone with adriamycin or adrenalectomy.
    Nemoto T; Rosner D; Diaz R; Dao T; Sponzo R; Cunningham T; Horton J; Simon R
    Cancer; 1978 Jun; 41(6):2073-7. PubMed ID: 657080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.